Tizanidine-1 (Tizanidine 1)
Tizanidine Tablet
Product Images NDC 63629-8533
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-8533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tizanidine-2 (Tizanidine 2)
Tizanidine-3 (Tizanidine 3)
Tizanidine-4 (Tizanidine 4)
The text describes an improvement in Ashworth Score with a mean dose of 26.8 mg. The Ashworth Score is a measure of muscle stiffness often used in the assessment of patients with neurological conditions. The improvement occurs at the end of titration and maintenance periods during a study that lasted 7 weeks. The endpoint was observed using the last observation carried forward method.*
Label (Lbl636298533)
This is a medication description for Tizanidine Tablets, USP containing 2.288 mg tizanidine HCL. It is advised to keep the medicine out of reach of children and stored at room temperature. It is recommended to dispense it in a tight, light-resistant container with a child-resistant closure. Tizanidine Tablets cannot be substituted with tizanidine capsules. The NDC number for this medication is 63629-8533-1, and it comes in a bottle of 150 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
